NHS England private patient units are too small to deal with private medical insurers. That is likely to be behind recent friction between NHS entities and private medical insurer Bupa.
African and Asian doctors have been brought to the UK from “red list” countries, from which “active recruitment” is banned, and forced to work illegal hours, according to reports.
HBI chats with Paresh Patel, the new CEO of UK-based OCL Vision and former MD of UK, Czechia and Poland-based ophthalmology platform Optegra, about his new role, and the ophthalmology market in general.
HBI understands a portfolio of homes owned by troubled UK elderly care operator Four Seasons will likely have to be split for sale, and some of these homes are not expected to sell until H2 2023.
Transform Hospital Group, a financially troubled UK-based medical aesthetics, cosmetic and weight loss surgery-focussed business, has been forced to lay off staff to secure its future.
Dermatology is hot right now. UK private equity firm Palatine has sold its stake in Veincentre, the UK’s largest chain varicose vein treatment provider, to CBPE Capital (another UK private equity group). This follows the acquisition of Dutch dermatology group Mauritskliniek last month.
The CMA (the UK's competition authority) has given the green light to the merger between NHS-focussed UK dental group Rodericks Dental and rival Dental Partners.
Are local authorities paying the right rate to the for-profit operators looking after our elderly - and what happens when operators push back and demand more? HBI catches up with Sanjeev Kanoria, the outspoken chairman and co-founder at private care provider Advinia Health Care.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
